Final report of University Hospital Hradec Kralove to the clinical trial protocol no. DRI11772

Abstract

Efficacy and Safety of SAR156597 in the Treatment of Idiopathic Pulmonary Fibrosis (IPF): A Randomized, Double-blind, Placebo-controlled, 52-week Dose-ranging Study

Keywords

• SAR156597
• Idiopathic Pulmonary Fibrosis (IPF)